INVIVOMAB Trademark

Trademark Overview


On Friday, January 5, 2024, a trademark application was filed for INVIVOMAB with the United States Patent and Trademark Office. The USPTO has given the INVIVOMAB trademark a serial number of 98343548. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, August 5, 2024. This trademark is owned by Bio X Cell, LLC. The INVIVOMAB trademark is filed in the Chemical Products category with the following description:

Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
invivomab

General Information


Serial Number98343548
Word MarkINVIVOMAB
Filing DateFriday, January 5, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, August 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkIN VIVO MAB
Goods and ServicesBiochemicals, namely, monoclonal antibodies for in vitro scientific or research use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, January 5, 2024
Primary Code001
First Use Anywhere DateMonday, January 1, 2018
First Use In Commerce DateMonday, January 1, 2018

Trademark Owner History


Party NameBio X Cell, LLC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLebanon, NH 03766

Trademark Events


Event DateEvent Description
Friday, January 5, 2024NEW APPLICATION ENTERED
Monday, April 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 1, 2024ASSIGNED TO EXAMINER
Monday, August 5, 2024NON-FINAL ACTION WRITTEN
Monday, August 5, 2024NON-FINAL ACTION E-MAILED
Monday, August 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED